ECHA is reporting on the progress made in 2019 in dossier and substance evaluation in line with Article 54 of REACH.

During 2019, progress was made on 97 substances. Evaluation was completed for 21 substances resulting in 12 draft decisions and nine conclusions. Another eight draft decisions were sent as a result of follow-up evaluation and 13 substance evaluations, from previous evaluation years, were concluded.

Of the 22 substance evaluation conclusions published in 2019, 12 concluded that no further risk management measures are currently needed, and 10 concluded that further risk management measures are necessary.

In 2019, ECHA launched several projects analysing multiple groups of substances, on whether compliance checks and substance evaluations could be done in parallel. The progress showed that such an approach is valuable: speeding up data collection and allowing decisions to be quickly made on the most appropriate ways to manage chemical risks. The combined approach will continue in 2020.

For the first group of five antimony containing substances, ECHA issued nine draft decisions (five under compliance check and four under substance evaluation) in 2019.